$HITK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HI TECH PHARMACAL CO INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HI TECH PHARMACAL CO INC. Get notifications about new insider transactions in HI TECH PHARMACAL CO INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 31.93 | 3,124 | 99,749 | 9,376 | |
| Dec 17 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 22.25 | 1,874 | 41,697 | 1,876 | |
| Dec 17 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 19.59 | 1,875 | 36,731 | 0 | |
| Dec 17 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 43.06 | 6,873 | 295,951 | 0 | 6.9 K to 0 (-100.00 %) |
| Dec 17 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 31.93 | 3,124 | 99,749 | 6,873 | 3.7 K to 6.9 K (+83.33 %) |
| Dec 17 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 22.25 | 1,874 | 41,697 | 3,749 | 1.9 K to 3.7 K (+99.95 %) |
| Dec 17 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 19.59 | 1,875 | 36,731 | 1,875 | 0 to 1.9 K |
| Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Option Exercise | M | 10.93 | 11,250 | 122,963 | 0 | |
| Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 43.13 | 11,250 | 485,213 | 521,510 | 532.8 K to 521.5 K (-2.11 %) |
| Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Buy | M | 10.93 | 11,250 | 122,963 | 532,760 | 521.5 K to 532.8 K (+2.16 %) |
| Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | M | 14.99 | 75,000 | 1,124,250 | 0 | |
| Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Buy | M | 14.99 | 75,000 | 1,124,250 | 1,339,612 | 1.3 M to 1.3 M (+5.93 %) |
| Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Payment of Exercise | F | 43.09 | 26,091 | 1,124,261 | 1,264,612 | 1.3 M to 1.3 M (-2.02 %) |
| Oct 10 2013 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 43.09 | 23,000 | 991,070 | 1,290,703 | 1.3 M to 1.3 M (-1.75 %) |
| Oct 08 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 24.95 | 1,500 | 37,425 | 7,875 | |
| Oct 08 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 43.10 | 1,500 | 64,650 | 0 | 1.5 K to 0 (-100.00 %) |
| Oct 08 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 24.95 | 1,500 | 37,425 | 1,500 | 0 to 1.5 K |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | M | 13.50 | 11,250 | 151,875 | 0 | |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Buy | M | 13.50 | 11,250 | 151,875 | 56,750 | 45.5 K to 56.8 K (+24.73 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 32.59 | 2,500 | 81,475 | 7,500 | |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 22.25 | 5,000 | 111,250 | 5,000 | |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 19.59 | 2,500 | 48,975 | 2,500 | |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 5.83 | 3,093 | 18,032 | 0 | |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 24.95 | 12,375 | 308,756 | 0 | |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Sell | S | 43.14 | 10,100 | 435,714 | 0 | 10.1 K to 0 (-100.00 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Sell | S | 43.15 | 15,368 | 663,129 | 10,100 | 25.5 K to 10.1 K (-60.34 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 32.59 | 2,500 | 81,475 | 25,468 | 23 K to 25.5 K (+10.88 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 22.25 | 5,000 | 111,250 | 22,968 | 18 K to 23 K (+27.83 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 19.59 | 2,500 | 48,975 | 17,968 | 15.5 K to 18 K (+16.16 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 5.83 | 3,093 | 18,032 | 15,468 | 12.4 K to 15.5 K (+24.99 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 24.95 | 12,375 | 308,756 | 12,375 | 0 to 12.4 K |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Option Exercise | M | 13.50 | 11,250 | 151,875 | 0 | |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 43.13 | 11,250 | 485,213 | 521,510 | 532.8 K to 521.5 K (-2.11 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Buy | M | 13.50 | 11,250 | 151,875 | 532,760 | 521.5 K to 532.8 K (+2.16 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | EVP & Chief Financ ... | Option Exercise | M | 5.83 | 6,250 | 36,438 | 0 | |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | EVP & Chief Financ ... | Option Exercise | M | 18.87 | 15,000 | 283,050 | 3,750 | |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | EVP & Chief Financ ... | Sell | S | 43.11 | 21,250 | 916,088 | 0 | 21.3 K to 0 (-100.00 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | EVP & Chief Financ ... | Buy | M | 5.83 | 6,250 | 36,438 | 21,250 | 15 K to 21.3 K (+41.67 %) |
| Oct 04 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | EVP & Chief Financ ... | Buy | M | 18.87 | 15,000 | 283,050 | 15,000 | 0 to 15 K |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 13.50 | 3,111 | 41,999 | 0 | |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 24.95 | 3,000 | 74,850 | 9,375 | |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 13.50 | 4,308 | 58,158 | 3,111 | |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 3,111 | 0 | 0 | 3.1 K to 0 (-100.00 %) |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 13.50 | 3,111 | 41,999 | 3,111 | 0 to 3.1 K |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 43.10 | 3,000 | 129,300 | 0 | 3 K to 0 (-100.00 %) |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 24.95 | 3,000 | 74,850 | 3,000 | 0 to 3 K |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 4,308 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 13.50 | 4,308 | 58,158 | 4,308 | 0 to 4.3 K |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 32.59 | 3,125 | 101,844 | 9,375 | |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 43.08 | 3,125 | 134,625 | 0 | 3.1 K to 0 (-100.00 %) |
| Oct 01 2013 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 32.59 | 3,125 | 101,844 | 3,125 | 0 to 3.1 K |
| May 24 2013 | HITK | HI TECH PHARMACAL ... | Egbaria Kamel | Chief Scientific Of ... | Option Exercise | A | 33.81 | 40,000 | 1,352,400 | 40,000 | |
| Mar 13 2013 | HITK | HI TECH PHARMACAL ... | Durrant Cameron | Option Exercise | A | 35.36 | 50,000 | 1,768,000 | 50,000 | ||
| Jan 28 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 10.68 | 1,611 | 17,205 | 17,139 | |
| Jan 28 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 10.68 | 6,250 | 66,750 | 0 | |
| Jan 28 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 38.00 | 7,861 | 298,718 | 0 | 7.9 K to 0 (-100.00 %) |
| Jan 28 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 10.68 | 1,611 | 17,205 | 7,861 | 6.3 K to 7.9 K (+25.78 %) |
| Jan 28 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 10.68 | 6,250 | 66,750 | 6,250 | 0 to 6.3 K |
| Feb 05 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 10.68 | 36 | 384 | 12,500 | |
| Feb 05 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 10.68 | 4,603 | 49,160 | 12,536 | |
| Feb 05 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 38.00 | 36 | 1,368 | 0 | 36 to 0 (-100.00 %) |
| Feb 05 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 10.68 | 36 | 384 | 36 | 0 to 36 |
| Feb 05 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 38.00 | 4,603 | 174,914 | 0 | 4.6 K to 0 (-100.00 %) |
| Feb 05 2013 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 10.68 | 4,603 | 49,160 | 4,603 | 0 to 4.6 K |
| Jan 11 2013 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | M | 11.56 | 112,500 | 1,300,500 | 0 | |
| Jan 11 2013 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Gift | G | 0.00 | 1,050 | 0 | 224,927 | 223.9 K to 224.9 K (+0.47 %) |
| Jan 11 2013 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Buy | M | 11.56 | 112,500 | 1,300,500 | 1,313,703 | 1.2 M to 1.3 M (+9.37 %) |
| Jan 11 2013 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Payment of Exercise | F | 37.06 | 35,092 | 1,300,510 | 1,201,203 | 1.2 M to 1.2 M (-2.84 %) |
| Jan 11 2013 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Gift | G | 0.00 | 350 | 0 | 1,236,295 | 1.2 M to 1.2 M (+0.03 %) |
| Nov 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | A | 31.93 | 10,000 | 319,300 | 10,000 | |
| Dec 12 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 22.25 | 1,876 | 41,741 | 3,750 | |
| Dec 12 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 19.59 | 1,875 | 36,731 | 1,875 | |
| Dec 12 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 5.83 | 1,875 | 10,931 | 0 | |
| Dec 12 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 35.44 | 5,626 | 199,385 | 0 | 5.6 K to 0 (-100.00 %) |
| Dec 12 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 22.25 | 1,876 | 41,741 | 5,626 | 3.8 K to 5.6 K (+50.03 %) |
| Dec 12 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 19.59 | 1,875 | 36,731 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
| Dec 12 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 5.83 | 1,875 | 10,931 | 1,875 | 0 to 1.9 K |
| Nov 15 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 8.31 | 2,832 | 23,534 | 0 | |
| Nov 15 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 2,832 | 0 | 0 | 2.8 K to 0 (-100.00 %) |
| Nov 15 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 8.31 | 2,832 | 23,534 | 2,832 | 0 to 2.8 K |
| Nov 09 2012 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | A | 31.93 | 30,000 | 957,900 | 30,000 | |
| Nov 09 2012 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | A | 31.93 | 50,000 | 1,596,500 | 50,000 | |
| Nov 09 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman-Busin ... | Option Exercise | A | 31.93 | 50,000 | 1,596,500 | 50,000 | |
| Nov 09 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | A | 31.93 | 12,500 | 399,125 | 12,500 | |
| Nov 09 2012 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Option Exercise | A | 31.93 | 10,000 | 319,300 | 10,000 | |
| Nov 09 2012 | HITK | HI TECH PHARMACAL ... | PUGLISI ANTHONY J | Director | Option Exercise | A | 31.93 | 10,000 | 319,300 | 10,000 | |
| Nov 09 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | A | 31.93 | 10,000 | 319,300 | 10,000 | |
| Nov 08 2012 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | M | 8.31 | 11,250 | 93,488 | 0 | |
| Nov 08 2012 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Buy | M | 8.31 | 11,250 | 93,488 | 45,500 | 34.3 K to 45.5 K (+32.85 %) |
| Oct 18 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 19.59 | 421 | 8,247 | 9,579 | |
| Oct 18 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 421 | 0 | 0 | 421 to 0 (-100.00 %) |
| Oct 18 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 19.59 | 421 | 8,247 | 421 | 0 to 421 |
| Oct 18 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 32.56 | 6,800 | 221,408 | 521,160 | 528 K to 521.2 K (-1.29 %) |
| Oct 18 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 33.47 | 3,200 | 107,104 | 527,690 | 530.9 K to 527.7 K (-0.60 %) |
| Oct 17 2012 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Option Exercise | M | 5.83 | 3,000 | 17,490 | 6,281 | |
| Oct 17 2012 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Sell | S | 32.75 | 3,000 | 98,250 | 0 | 3 K to 0 (-100.00 %) |
| Oct 17 2012 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Buy | M | 5.83 | 3,000 | 17,490 | 3,000 | 0 to 3 K |
| Oct 17 2012 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 32.60 | 29,441 | 959,777 | 1,235,945 | 1.3 M to 1.2 M (-2.33 %) |
| Oct 17 2012 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 32.97 | 20,559 | 677,830 | 1,265,386 | 1.3 M to 1.3 M (-1.60 %) |
| Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Option Exercise | M | 8.31 | 11,250 | 93,488 | 0 | |
| Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 33.01 | 11,250 | 371,363 | 531,160 | 542.4 K to 531.2 K (-2.07 %) |
| Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Buy | M | 8.31 | 11,250 | 93,488 | 542,410 | 531.2 K to 542.4 K (+2.12 %) |
| Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 34.01 | 707 | 24,045 | 531,160 | 531.9 K to 531.2 K (-0.13 %) |
| Oct 15 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman, Busi ... | Sell | S | 33.18 | 9,293 | 308,342 | 531,867 | 541.2 K to 531.9 K (-1.72 %) |
| Aug 17 2012 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 5.83 | 12,500 | 72,875 | 6,250 | |
| Aug 17 2012 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 35.50 | 12,500 | 443,750 | 0 | 12.5 K to 0 (-100.00 %) |
| Aug 17 2012 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 5.83 | 12,500 | 72,875 | 12,500 | 0 to 12.5 K |
| Jul 24 2012 | HITK | HI TECH PHARMACAL ... | Caskey Davis S | Officer | Option Exercise | A | 32.59 | 5,000 | 162,950 | 5,000 | |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | PUGLISI ANTHONY J | Director | Option Exercise | A | 32.59 | 10,000 | 325,900 | 10,000 | |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | Egbaria Kamel | Chief Scientific Of ... | Option Exercise | M | 23.10 | 11,342 | 262,000 | 28,658 | |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | Egbaria Kamel | Chief Scientific Of ... | Sell | S | 32.56 | 11,342 | 369,296 | 0 | 11.3 K to 0 (-100.00 %) |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | Egbaria Kamel | Chief Scientific Of ... | Buy | M | 23.10 | 11,342 | 262,000 | 11,342 | 0 to 11.3 K |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | A | 32.59 | 10,000 | 325,900 | 10,000 | |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | A | 32.59 | 50,000 | 1,629,500 | 50,000 | |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Gift | G | 0.00 | 1,000 | 0 | 1,285,945 | 1.3 M to 1.3 M (-0.08 %) |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Option Exercise | A | 32.59 | 10,000 | 325,900 | 10,000 | |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | A | 32.59 | 10,000 | 325,900 | 10,000 | |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | A | 32.59 | 30,000 | 977,700 | 30,000 | |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 19.95 | 4,983 | 99,411 | 0 | |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 32.00 | 4,983 | 159,456 | 0 | 5 K to 0 (-100.00 %) |
| Jul 18 2012 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 19.95 | 4,983 | 99,411 | 4,983 | 0 to 5 K |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 22.25 | 1,874 | 41,697 | 5,626 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 19.59 | 3,750 | 73,463 | 3,750 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 23.99 | 5,000 | 119,950 | 0 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | A | 32.59 | 12,500 | 407,375 | 12,500 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 5.83 | 3,750 | 21,863 | 1,875 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 10.68 | 3,750 | 40,050 | 0 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 10.68 | 2,500 | 26,700 | 0 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 32.41 | 10,624 | 344,324 | 0 | 10.6 K to 0 (-100.00 %) |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 22.25 | 1,874 | 41,697 | 10,624 | 8.8 K to 10.6 K (+21.42 %) |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 19.59 | 3,750 | 73,463 | 8,750 | 5 K to 8.8 K (+75.00 %) |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 23.99 | 5,000 | 119,950 | 5,000 | 0 to 5 K |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 29.15 | 3,750 | 109,313 | 0 | 3.8 K to 0 (-100.00 %) |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 5.83 | 3,750 | 21,863 | 3,750 | 0 to 3.8 K |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 29.35 | 3,750 | 110,063 | 0 | 3.8 K to 0 (-100.00 %) |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 10.68 | 3,750 | 40,050 | 3,750 | 0 to 3.8 K |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 29.54 | 2,500 | 73,850 | 0 | 2.5 K to 0 (-100.00 %) |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 10.68 | 2,500 | 26,700 | 2,500 | 0 to 2.5 K |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 14.99 | 401 | 6,011 | 6,849 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | A | 32.59 | 10,000 | 325,900 | 10,000 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 14.99 | 4,000 | 59,960 | 7,250 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 13.50 | 1,956 | 26,406 | 7,419 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 8.31 | 1,406 | 11,684 | 2,832 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 32.05 | 401 | 12,852 | 0 | 401 to 0 (-100.00 %) |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 14.99 | 401 | 6,011 | 401 | 0 to 401 |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 32.11 | 4,000 | 128,440 | 0 | 4 K to 0 (-100.00 %) |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 14.99 | 4,000 | 59,960 | 4,000 | 0 to 4 K |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 29.83 | 1,956 | 58,347 | 0 | 2 K to 0 (-100.00 %) |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 13.50 | 1,956 | 26,406 | 1,956 | 0 to 2 K |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 1,406 | 0 | 0 | 1.4 K to 0 (-100.00 %) |